end of life - Nursing Case Study
Pathophysiology
• Primary mechanism: Multi-organ failure - As the body approaches end of life, vital organs such as the heart, liver, and kidneys progressively lose function due to decreased perfusion and cellular metabolism, leading to systemic decline and eventual shutdown.
• Secondary mechanism: Respiratory failure - Compromised gas exchange due to weakened respiratory muscles or central nervous system decline results in inadequate oxygenation and increased carbon dioxide levels, further exacerbating organ dysfunction.
• Key complication: Metabolic imbalance - Accumulation of waste products and electrolyte disturbances from failing organs lead to metabolic acidosis and further disrupt homeostasis, complicating symptom management and comfort care.
Patient Profile
Demographics:
72-year-old female, retired school teacher
History:
• Key past medical history: Stage IV lung cancer, chronic obstructive pulmonary disease (COPD), hypertension
• Current medications: Morphine, albuterol inhaler, lisinopril, dexamethasone
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing difficulty breathing and persistent cough
• Key symptoms: Severe fatigue, loss of appetite, intermittent confusion, pain in the chest
• Vital signs: Blood pressure 92/58 mmHg, heart rate 110 bpm, respiratory rate 28 breaths per minute, oxygen saturation 84% on room air, temperature 37.2°C
Section 1
As the healthcare team continues to monitor the patient, there is a noticeable change in her status. Her respiratory distress has intensified, and she is now experiencing more frequent episodes of confusion and disorientation. The patient is becoming increasingly lethargic, and her decreased level of consciousness raises concerns. The family reports that she has been sleeping more and is difficult to arouse. Upon assessment, the patient's vitals reveal a further decline in oxygen saturation, now at 80% despite supplemental oxygen at 2L via nasal cannula. Her heart rate has increased to 120 bpm, and her respiratory rate has become irregular, with periods of apnea noted.
Laboratory results are consistent with the anticipated progression of her condition. Arterial blood gas analysis shows a pH of 7.28, indicating worsening metabolic acidosis, with a pCO2 of 60 mmHg and a bicarbonate level of 18 mmol/L, suggesting a mixed respiratory and metabolic acidosis. Serum electrolytes reveal hyperkalemia with a potassium level of 5.8 mEq/L, which poses a risk for cardiac complications. Creatinine levels are elevated, reflecting deteriorating renal function, with a value of 2.5 mg/dL, indicating acute kidney injury likely due to low perfusion and dehydration.
These findings necessitate a reevaluation of the current management plan. The healthcare team must consider the balance between aggressive interventions and maintaining the patient's comfort, respecting her end-of-life wishes. Discussions with the family about the goals of care, including potential adjustments to medication and oxygen therapy, are crucial to align the treatment approach with the patient’s preferences. As the patient's condition evolves, the focus will shift towards ensuring symptom control and quality of life, prompting further discussions about palliative care options and the possibility of hospice involvement.
Section 2
As the patient's condition progresses, the healthcare team notes several new complications requiring immediate attention. The patient's respiratory status has further deteriorated, evidenced by an increased use of accessory muscles and a pronounced paradoxical breathing pattern. Her oxygen saturation has dropped to 75% despite increasing supplemental oxygen to 4L via nasal cannula, prompting consideration of whether to initiate high-flow oxygen therapy or non-invasive positive pressure ventilation. However, given the patient's end-of-life preferences, the team must weigh the benefits of these interventions against her comfort and potential distress.
Additionally, the patient's neurological status has declined significantly. She is now minimally responsive to verbal and painful stimuli, with a Glasgow Coma Scale score of 8. Her pupils are sluggishly reactive to light, and she exhibits a positive Babinski sign bilaterally, indicating a possible progression of metabolic encephalopathy. The family is increasingly concerned, seeking guidance on what these changes mean for her prognosis and how best to honor her wishes for a peaceful transition.
In light of these developments, the healthcare team initiates a family meeting to discuss the current clinical picture, emphasizing the importance of symptom management and quality of care. They explore options for enhancing comfort, such as transitioning to morphine for respiratory distress and revisiting the potential role of hospice care. As the patient’s journey continues, the focus remains on ensuring dignity and alleviating suffering, guiding the family through this challenging time with compassion and clarity.
Section 3
As the healthcare team gathers to reassess the patient's condition, they note several critical findings that demand immediate attention. Her vital signs reveal hypotension, with blood pressure readings of 85/50 mmHg, and tachycardia, with a heart rate of 120 beats per minute. Her respiratory rate is elevated at 30 breaths per minute, indicating increased respiratory distress. Despite the use of supplemental oxygen, her oxygen saturation remains critically low at 78%. The patient's skin is cool and mottled, suggesting compromised peripheral perfusion. These changes point to a possible onset of multi-organ dysfunction, likely exacerbated by her underlying condition and recent metabolic encephalopathy.
In light of these findings, the team conducts a series of diagnostic tests, including arterial blood gases (ABG) and a complete metabolic panel. The ABG results show severe respiratory acidosis, with a pH of 7.25 and a significantly elevated pCO2 of 68 mmHg, confirming respiratory failure. The metabolic panel reveals worsening renal function, with creatinine levels rising to 2.5 mg/dL and blood urea nitrogen at 45 mg/dL, indicating acute kidney injury. These laboratory findings corroborate the clinical picture of a systemic decline, necessitating a swift yet thoughtful approach to end-of-life care.
The healthcare team reconvenes to discuss the implications of these results with the family. They emphasize the importance of prioritizing the patient's comfort while considering possible interventions to alleviate her distress. Discussions center on the potential benefits of low-dose morphine to ease respiratory effort and anxiety, as well as the option to initiate hospice care for comprehensive support. The family, informed by the team's compassionate guidance, agrees to focus on measures that align with the patient's wishes for a dignified and peaceful transition, marking a pivotal moment in her care journey.
Section 4
As the healthcare team continues to monitor the patient's status following the initiation of comfort care measures, including low-dose morphine, a new complication arises. The patient's respiratory pattern begins to show signs of Cheyne-Stokes breathing, characterized by alternating periods of tachypnea and apnea. This irregular pattern indicates a further decline in her respiratory function, potentially linked to a combination of her metabolic encephalopathy and the effects of morphine, which, although intended to alleviate distress, can also depress respiratory drive. Despite these changes, the patient appears more relaxed and less agitated, suggesting that the medication is effectively managing her anxiety and discomfort.
Concurrent with these observations, the patient's neurological status continues to deteriorate. She no longer responds to verbal stimuli and exhibits a Glasgow Coma Scale score of 6, indicating severe impairment. Pupillary reactions are sluggish, and her grip strength is markedly diminished, suggesting progression of her encephalopathy and possible cerebral hypoperfusion. These findings necessitate continuous assessment and underscore the importance of the team's commitment to providing comprehensive palliative care.
In light of these developments, the healthcare team discusses the situation with the family, emphasizing the body's natural process as it approaches the end of life. They reiterate the focus on ensuring comfort and dignity, reassuring the family that the patient is not in pain. The team also prepares the family for what to expect in the coming hours and days, offering support and resources to help them through this emotionally challenging time. By maintaining open communication and a compassionate approach, the team ensures that the patient's final journey is as peaceful as possible, while remaining attentive to any new complications that may arise.
Section 5
As the healthcare team continues their vigilant monitoring, a new complication emerges: the patient develops evidence of acute renal insufficiency. Recent laboratory results reveal an elevation in creatinine and blood urea nitrogen levels, indicating a decline in renal function. This could be attributed to a combination of factors, including decreased perfusion secondary to her progressive multi-organ failure and the possible effects of morphine-induced hypotension. The patient’s blood pressure has shown a downward trend, now averaging around 85/50 mmHg, which may be contributing to reduced renal blood flow and subsequent renal impairment.
In response to these developments, the team must carefully balance fluid management to avoid exacerbating the patient's respiratory status, given her compromised breathing patterns. They decide to maintain a conservative fluid approach, utilizing minimal isotonic fluids to support circulation without overloading her system. The healthcare team also considers adjusting the morphine dosage, ensuring it remains effective for comfort without further depressing her blood pressure or respiratory drive.
Throughout this phase, the family's understanding of the patient's condition is crucial. The team re-engages with the family to explain the significance of the renal findings and the shifts in the patient’s hemodynamic status, reinforcing the primary goal of comfort care. They explain that such changes are part of the natural trajectory as the body systems gradually shut down. By providing this context, the team helps the family prepare for the possibility of further decline while reinforcing their commitment to minimizing distress and maintaining dignity in the patient’s final hours.